Elisavet Ntavli

Elisavet Ntavli is currently a Scientist II at IMU Biosciences since November 2024. Previously, Ntavli held multiple positions at Quell Therapeutics from November 2020 to October 2024, including Senior Research Associate and Research Associate in Translational Research. Prior experience includes serving as a Research Technician at University College London’s Walker Lab within the Institute of Immunity & Transplantation from July 2016 to November 2020, focusing on identifying markers to predict clinical responses in cancer patients undergoing immunotherapy. Ntavli also worked as a Research Assistant at Imperial College London's National Heart & Lung Institute for a short term in 2016, conducting research on Group 2 Innate Lymphoid Cells in relation to peanut allergy. Ntavli holds a Master of Science in Immunology from Imperial College London and a Bachelor of Science in Biology from Aristotle University of Thessaloniki.